# TERIPARATIDE
> **ANDA208569** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2023-11-16
## Drug
- **FDA Application Number:** ANDA208569
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TERIPARATIDE
- **Generic name:** TERIPARATIDE
- **Active ingredients:** TERIPARATIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2023-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208569)
---
*AI Analytics · CC0 1.0*